How to Decide Exactly Where to Get Fillers and Botox
Your forehead isn't the only spot you can get an injectable. Here's what you need to know about filler and Botox injection sites — both well-established and newly available, according to Shape.
Your forehead isn't the only spot you can get an injectable. Here's what you need to know about filler and Botox injection sites — both well-established and newly available, according to Shape.
The injectable, known as Restylane Contour in the US, achieved a 94.4% responder rate at six months, with improvements sustained through 12 months.
The International Society of Aesthetic Plastic Surgery has elected plastic surgeon Ozan Sozer, MD, as president-elect, with his term as president set to begin in 2028.
The licensing and distribution agreement expands the company’s injectable portfolio into the skin quality category.
Read MoreThe product is the first botulinum toxin type E approved for aesthetic use and is designed to deliver faster onset and shorter-lasting results than traditional neurotoxins.
Read MoreClinical trial results showed improvements in neck appearance lasting up to six months following treatment.
Read MoreFacial plastic surgeons report growing patient interest in facelifts as more individuals reconsider long-term filler use and seek natural-looking facial rejuvenation.
Read MoreThe botulinum neurotoxin type E candidate is designed for a faster onset and shorter duration of effect than currently available neurotoxin treatments.
Read MoreThe neurotoxin, developed by Claruvis Pharmaceutical, uses a precision-engineered recombinant manufacturing process for botulinum toxin type A.
Read MoreAgency requests additional manufacturing information and does not cite safety or efficacy concerns or require new clinical studies.
Read MoreEmily Hu, MD, shares insights from a recent report on HA injectables, examining patient perceptions, persistent myths, and clinical realities.
Read MoreFiller cleared for infraorbital hollow and horizontal forehead lines in Europe.
Read MoreAgreement for CellREDM highlights growing interest in regenerative injectables used alongside fillers.
Read MoreAllergan Aesthetics presented new research at AMWC 2026 indicating a shift toward subtle, natural-looking outcomes in hyaluronic acid injectables and emphasizing the role of personalized treatment approaches.
Read MoreThe expanded indication is based on clinical data showing high responder rates and results lasting up to 18 months, with no serious adverse events reported.
Read MoreThe company presented clinical data on its PCL-based collagen stimulator, positioning it within a shift toward treatments targeting skin laxity.
Read MoreGalderma has received regulatory approval in the European Union, United States, and Canada for a new syringe designed for use with its NASHA lidocaine range of Restylane products.
Read MoreJohnny Franco, MD, FACS, discusses how implant removals, biologic innovation, and patient demand for long-term tissue health are accelerating a regenerative shift in body aesthetics.
Read More